Correlation Between Pasithea Therapeutics and Evotec SE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Evotec SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Evotec SE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Evotec SE ADR, you can compare the effects of market volatilities on Pasithea Therapeutics and Evotec SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Evotec SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Evotec SE.

Diversification Opportunities for Pasithea Therapeutics and Evotec SE

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pasithea and Evotec is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Evotec SE ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evotec SE ADR and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Evotec SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evotec SE ADR has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Evotec SE go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and Evotec SE

Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to under-perform the Evotec SE. But the stock apears to be less risky and, when comparing its historical volatility, Pasithea Therapeutics Corp is 2.44 times less risky than Evotec SE. The stock trades about -0.24 of its potential returns per unit of risk. The Evotec SE ADR is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  386.00  in Evotec SE ADR on August 28, 2024 and sell it today you would earn a total of  103.00  from holding Evotec SE ADR or generate 26.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pasithea Therapeutics Corp  vs.  Evotec SE ADR

 Performance 
       Timeline  
Pasithea Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pasithea Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Evotec SE ADR 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Evotec SE ADR are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Evotec SE displayed solid returns over the last few months and may actually be approaching a breakup point.

Pasithea Therapeutics and Evotec SE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pasithea Therapeutics and Evotec SE

The main advantage of trading using opposite Pasithea Therapeutics and Evotec SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Evotec SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will offset losses from the drop in Evotec SE's long position.
The idea behind Pasithea Therapeutics Corp and Evotec SE ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years